Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 37 min ago
PreprintAll rights reservedbioRxiv

Systematic comparison of gliflozins identifies a selective anti-calcifying effect of canagliflozin beyond canonical SGLT2 inhibition

9 more authors
  1. 1Institut National de la Sante et de la Recherche Medicale (INSERM), U1297, Institute of Cardiovascular and Metabolic Disease, Toulouse, France; Universite de To

Related

  1. Cross-platform comparison of diabetic foot ulcer transcriptomes identifies partially concordant disease-associated signals
    Shiqin Huang, Yukun Li
    PLOS OnePeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCell biologyPLOSPMC
  2. Mortality and persistence in therapy in elderly subjects with type 2 diabetes receiving gliflozins or incretins
    Alice Del Zoppo, Diego Moriconi, Eleni Rebelos +2
    Journal of Endocrinological InvestigationPeer-reviewedCC BY-NC-ND 4.0Full textEndocrinology & metabolismPMC
  3. Calcifying Odontogenic Cyst Exhibiting Focal Clear Cell Change: A Diagnostic Challenge
    Keya Sarkar, Sudeshna Bagchi, S. K. Abdul Mahmud +3
    Contemporary Clinical DentistryPeer-reviewedCC BY-NC-SAFull textGeneral medicineDOAJ
  4. The ghost in the jaw: A case report on three cases of calcifying odontogenic cyst
    Ankita Khairwar, Prashanthi Reddy, Ajay Parihar +2
    Journal of Clinical SciencesPeer-reviewedCC BY-NC-SAFull textGeneral medicineDOAJ
  5. Canagliflozin reduces the recovery of intracellular uropathogenic Escherichia coli from uroepithelial cells and affects α-hemolysin function
    Annika Hilger, Annika Adick, Johannes Putze +2
    Scientific ReportsPeer-reviewedCC BY 4.0Full textEndocrinology & metabolismCrossref
BibTeX
@misc{fernandez2026systematic,
  title = {{Systematic comparison of gliflozins identifies a selective anti-calcifying effect of canagliflozin beyond canonical SGLT2 inhibition}},
  author = {L. Fernandez and M. Brunet and E. Ballongue and V. Ducos and M. Buleon and G. Feuillet and E. Galaricha and A. Mairal and A. Del Bello and N. Auge and N. Gayrard and J. Laguet and F. Raynaud and J. M. Diaz-Tocados and A. Thomas and M. Chabbert and S. Arefin and K. Kublickene and S. Peter and J. P. Schanstra and J. Klein},
  howpublished = {bioRxiv},
  year = {2026},
  month = nov,
  doi = {10.64898/2026.11.05.764503},
  url = {https://www.biorxiv.org/content/10.64898/2026.11.05.764503v1},
}
RIS
TY  - UNPB
TI  - Systematic comparison of gliflozins identifies a selective anti-calcifying effect of canagliflozin beyond canonical SGLT2 inhibition
AU  - L. Fernandez
AU  - M. Brunet
AU  - E. Ballongue
AU  - V. Ducos
AU  - M. Buleon
AU  - G. Feuillet
AU  - E. Galaricha
AU  - A. Mairal
AU  - A. Del Bello
AU  - N. Auge
AU  - N. Gayrard
AU  - J. Laguet
AU  - F. Raynaud
AU  - J. M. Diaz-Tocados
AU  - A. Thomas
AU  - M. Chabbert
AU  - S. Arefin
AU  - K. Kublickene
AU  - S. Peter
AU  - J. P. Schanstra
AU  - J. Klein
PY  - 2026
DA  - 2026/11/05
PB  - bioRxiv
DO  - 10.64898/2026.11.05.764503
UR  - https://www.biorxiv.org/content/10.64898/2026.11.05.764503v1
ER  -